We are live on ! Find out more
CCM

Cinctive Capital Management Portfolio holdings

AUM $1.53B
1-Year Est. Return 48.83%
This Fund
S&P 500
This Quarter Est. Return
+11.37%
1 Year Est. Return
+48.83%
3 Year Est. Return
+143.95%
5 Year Est. Return
+199.46%
10 Year Est. Return
AUM
$2.09B
AUM Growth
+$200M
Cap. Flow
+$51.2M
Cap. Flow %
2.45%
Top 10 Hldgs %
13.97%
Holding
550
New
196
Increased
89
Reduced
103
Closed
157

Top Buys

Rank Stock Value
1
CYBR
CyberArk
CYBR
+$28.2M
2
YUM icon
Yum! Brands
YUM
+$20.8M
3
TXRH icon
Texas Roadhouse
TXRH
+$20.1M
4
HUBS icon
HubSpot
HUBS
+$20M
5
ROST icon
Ross Stores
ROST
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 15.58%
3 Consumer Discretionary 14.04%
4 Financials 11.38%
5 Industrials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBM icon
276
Hudbay
HBM
$10.4B
$1.49M 0.07%
+98,356
New +$1.13M
WBD icon
277
CALL
Warner Bros
WBD
$65.8B
$1.46M 0.07%
+75,000
New +$1.02M
H icon
278
Hyatt Hotels
H
$16.2B
$1.45M 0.07%
10,242
-45,885
-82% -$6.58M
WBD icon
279
Warner Bros
WBD
$65.8B
$1.38M 0.07%
+70,737
New +$964K
IDYA icon
280
IDEAYA Biosciences
IDYA
$3.4B
$1.36M 0.07%
49,946
+32,953
+194% +$797K
CGON icon
281
CG Oncology
CGON
$6.09B
$1.31M 0.06%
32,558
-52,298
-62% -$1.52M
RNAM
282
DELISTED
Avidity Biosciences
RNAM
$1.31M 0.06%
+30,077
New +$1.22M
IWM icon
283
iShares Russell 2000 ETF
IWM
$81.5B
$1.3M 0.06%
+5,372
New +$1.23M
BSX icon
284
Boston Scientific
BSX
$71.6B
$1.29M 0.06%
+13,254
New +$1.37M
PFE icon
285
CALL
Pfizer
PFE
$142B
$1.27M 0.06%
+50,000
New +$1.23M
FCX icon
286
Freeport-McMoran
FCX
$91.1B
$1.25M 0.06%
31,976
-201,790
-86% -$8.75M
EXAS
287
DELISTED
Exact Sciences
EXAS
$1.24M 0.06%
+22,614
New +$1.13M
PANW icon
288
Palo Alto Networks
PANW
$281B
$1.22M 0.06%
+6,001
New +$1.15M
DRVN icon
289
Driven Brands
DRVN
$2.45B
$1.22M 0.06%
75,643
-14,272
-16% -$249K
CARR icon
290
Carrier Global
CARR
$51.7B
$1.18M 0.06%
+19,807
New +$1.35M
CC icon
291
Chemours
CC
$2.54B
$1.18M 0.06%
74,457
-258,396
-78% -$3.75M
VSXY
292
Victoria's Secret
VSXY
$7B
$1.17M 0.06%
43,289
-310,637
-88% -$6.98M
CDTX
293
DELISTED
Cidara Therapeutics
CDTX
$1.16M 0.06%
+12,066
New +$770K
DKNG icon
294
DraftKings
DKNG
$11.5B
$1.15M 0.05%
+30,663
New +$1.36M
SEE
295
DELISTED
Sealed Air
SEE
$1.14M 0.05%
+32,349
New +$1.03M
ACLX
296
DELISTED
Arcellx
ACLX
$1.12M 0.05%
13,626
-3,913
-22% -$282K
NBIS
297
Nebius Group N.V.
NBIS
$56.1B
$1.11M 0.05%
+9,859
New +$685K
REGN icon
298
Regeneron Pharmaceuticals
REGN
$78.6B
$1.09M 0.05%
1,937
-1,172
-38% -$663K
GDRX icon
299
GoodRx Holdings
GDRX
$1.07B
$1.07M 0.05%
251,937
+161,937
+180% +$712K
BRKR icon
300
Bruker
BRKR
$9.73B
$1.07M 0.05%
32,798
-101,048
-75% -$3.6M

Similar funds

Cinctive Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Cinctive Capital Management held 550 positions worth $2.09B, up 11% from $1.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Cinctive Capital Management's Q3 2025 filing shows 196 new, 89 increased, 103 reduced and 157 closed positions. Its largest new stake was Yum! Brands: 141,561 shares worth $21.5M. The largest sale was Blueprint Medicines, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Cinctive Capital Management's largest Q3 2025 buy was Yum! Brands: 141,561 shares worth $21.5M.
  • Cinctive Capital Management added most to CyberArk in Q3 2025, an estimated $28.2M increase.
  • Cinctive Capital Management's biggest Q3 2025 reduction was Bloom Energy, cutting an estimated $30M.
  • Cinctive Capital Management fully exited Blueprint Medicines in Q3 2025, selling an estimated $34M.
  • Cinctive Capital Management's ten largest holdings make up 14% of its $2.09B portfolio in Q3 2025.
  • Cinctive Capital Management opened 196 new positions and closed 157 in Q3 2025.
  • Cinctive Capital Management's portfolio value rose 11% quarter-over-quarter to $2.09B.

Based on Cinctive Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.